{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"77"},{"groupId":"OG002","value":"129"}]}],"title":"mAB based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"213"},{"groupId":"OG002","value":"128"}]}],"title":"mAB/IMID based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"156"},{"groupId":"OG001","value":"119"},{"groupId":"OG002","value":"69"}]}],"title":"mAB/PI based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"}]}],"title":"mAB/alkalytor based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"12"}]}],"title":"mAB/IMID/PI based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"49"}]}],"title":"Cytotoxic"},{"categories":[{"measurements":[{"groupId":"OG000","value":"515"},{"groupId":"OG001","value":"361"},{"groupId":"OG002","value":"118"}]}],"title":"IMID based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"366"},{"groupId":"OG001","value":"204"},{"groupId":"OG002","value":"101"}]}],"title":"PI based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"33"}]}],"title":"Alkylator based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"608"},{"groupId":"OG001","value":"295"},{"groupId":"OG002","value":"115"}]}],"title":"PI/IMID based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"351"},{"groupId":"OG001","value":"137"},{"groupId":"OG002","value":"57"}]}],"title":"PI/alkylator based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"123"},{"groupId":"OG001","value":"119"},{"groupId":"OG002","value":"57"}]}],"title":"IMID/alkylator based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"7"}]}],"title":"PI/IMID/alkylator based"},{"categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"46"}]}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1490"},{"groupId":"OG001","value":"1057"},{"groupId":"OG002","value":"807"}]}],"title":"Unknown"}],"denoms":[{"counts":[{"groupId":"OG000","value":"4224"},{"groupId":"OG001","value":"2748"},{"groupId":"OG002","value":"1734"}],"units":"Participants"}],"description":"Drug classes were based on the earliest regimen in each corresponding Line of Therapy. The data for this outcome measure was analyzed as per line of therapy.","groups":[{"description":"The most common treatment regimens prescribed in participants treated in 1st line of therapy were PI+IMiD, PI+AA, and PI treatment as part of their index regimen while enrolled in the study and were observed until study discontinuation, death or end of study (up to approximately 5 years).","id":"OG000","title":"1st Line of Therapy"},{"description":"The most common treatment regimens prescribed in participants treated in 2nd line of therapy were PI+IMiD, IMiD, and PI treatment as part of their index regimen while enrolled in the study and were observed until study discontinuation, death or end of study (up to approximately 5 years).","id":"OG001","title":"2nd Line of Therapy"},{"description":"The most common treatment regimens prescribed in participants treated in 3rd line of therapy were IMiD, PI+IMiD, and mAB+IMiD treatment as part of their index regimen while enrolled in the study and were observed until study discontinuation, death or end of study (up to approximately 5 years).","id":"OG002","title":"3rd Line of Therapy"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All Enrolled Population included all participants who signed informed consent. Participants were reported more than once in each line of therapy. Data is reported only for 1st, 2nd and 3rd line of therapy.","reportingStatus":"POSTED","timeFrame":"Baseline up to 5 years","title":"Number of Treatment Sequencing","type":"SECONDARY","unitOfMeasure":"Participants"}